1. LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of β-catenin
    Linbo Wang et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef
  2. Human Epidermal Growth Factor Receptor 2 Status in Gastric Carcinomas with Distinctive Prevalent Cribriform Component
    Antonio Ieni et al, 2018, Disease Markers CrossRef
  3. Autophagy in advanced low- and high-grade tubular adenocarcinomas of the stomach: An ultrastructural investigation
    Rosario Alberto Caruso et al, 2018, Ultrastructural Pathology CrossRef
  4. Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer
    Naoyuki Tominaga et al, 2016, Gastric Cancer CrossRef
  5. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
    Angela N. Bartley et al, 2017, Journal of Clinical Oncology CrossRef
  6. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies
    Antonio Ieni et al, 2020, Journal of Personalized Medicine CrossRef
  7. Alteration in key oncoprotein expression in gastric adenocarcinoma – An immunohistochemical study
    Pragya Jain et al, 2023, Journal of Cancer Research and Therapeutics CrossRef
  8. Autophagy-related Prognostic Signature in HER2 Positive Gastric Carcinomas
    Antonio Ieni et al, 2022, Current Molecular Medicine CrossRef
  9. HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin
    Rosaria Ruggeri et al, 2016, International Journal of Molecular Sciences CrossRef
  10. Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer
    Jing Chen et al, 2016, Scientific Reports CrossRef
  11. Mast Cell Interaction with Neutrophils in Human Gastric Carcinomas: Ultrastructural Observations
    Antonio Ieni et al, 2016, Analytical Cellular Pathology CrossRef
  12. Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab
    Charles S Fuchs et al, 2016, British Journal of Cancer CrossRef
  13. Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma
    Ayesha Ahmed et al, 2018, Libyan Journal of Medicine CrossRef
  14. HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach
    A. Ieni et al, 2015, Disease Markers CrossRef
  15. Discordance Rate of HER2 Status in Primary Gastric Carcinomas and Synchronous Lymph Node Metastases: A Multicenter Retrospective Analysis
    Antonio Ieni et al, 2014, International Journal of Molecular Sciences CrossRef
  16. HER2Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
    Angela N. Bartley et al, 2016, American Journal of Clinical Pathology CrossRef
  17. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
    Angela N. Bartley et al, 2017, Journal of Oncology Practice CrossRef
  18. Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis
    H. Jiang et al, 2017, Clinical and Translational Oncology CrossRef
  19. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
    Angela N. Bartley et al, 2016, Archives of Pathology & Laboratory Medicine CrossRef
  20. Real-world association of HER2/ERBB2concordance with trastuzumab clinical benefit in advanced esophagogastric cancer
    Stacey M Stein et al, 2021, Future Oncology CrossRef
  21. Systemic therapy for gastric cancer: Perioperative strategies and beyond
    Christopher Cann et al, 2022, Journal of Surgical Oncology CrossRef